InfoLogix granted extension of time to regain compliance with NASDAQ listing requirements

InfoLogix, Inc. (Nasdaq: IFLG), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that it received a letter from NASDAQ on July 8, 2010, stating that a NASDAQ Hearings Panel (the "Panel") granted the Company's request for an extension of time, as permitted under NASDAQ's Listing Rules, to regain compliance with the $2.5 million minimum stockholders' equity requirement for continued listing on the NASDAQ Stock Market.  As previously disclosed, NASDAQ notified the Company on April 20, 2010 that it had not regained compliance with the minimum stockholders' equity requirement and that the Company's common stock was subject to delisting unless the Company requested a hearing. The Company timely requested a hearing and appeared before the Panel on June 10, 2010.  

The extension granted by the Panel requires, among other things, the occurrence of certain events by August 15, 2010 and the Company's ability to regain compliance with all the requirements for continued listing on NASDAQ by October 18, 2010.  Under NASDAQ's Listing Rules, this date represents the maximum length of time that a Panel may grant to regain compliance.  While the Company is diligently taking steps to comply with the Panel decision, there can be no assurances that the Company will be able to do so.  

Source:

InfoLogix, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals AI's potential and pitfalls in medical diagnosis